Concerns over minimally invasive heart valve surgery
A new type of heart valve surgery known as transcatheter aortic valve implantation "cannot be justified on medical or cost effectiveness grounds" warn experts in a paper published in BMJ today.
Cardiology
Jul 31, 2012 |
not rated yet |
0
Package inserts overstate diagnostic TB tests' accuracy
Clinicians and laboratory professionals often rely on manufacturers' package inserts to assess the accuracy of diagnostic medical tests. However, package inserts frequently greatly overstate such tests' accuracy, according ...
Diseases, Conditions, Syndromes
Jul 17, 2012 |
not rated yet |
0
UNAIDS welcomes US approval of drug to stop HIV
The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.
HIV & AIDS
Jul 17, 2012 |
not rated yet |
0
US approves first pill to help prevent HIV
(AP) — The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
HIV & AIDS
Jul 16, 2012 |
4 / 5 (1) |
0
Hong Kong's first anti-cancer drug granted with US FDA IND
(Medical Xpress) -- The discovery of a new drug for liver cancer by researchers of The Hong Kong Polytechnic University (PolyU) and local medical practitioner has born fruit. After completing clinical trials locally, the ...
Cancer
Jun 29, 2012 |
not rated yet |
0
Roche probed over faulty drug-safety reporting
Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.
Medications
Jun 21, 2012 |
4 / 5 (1) |
0
FDA panel urges approval for Pfizer arthritis drug
An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.
Arthritis & Rheumatism
May 09, 2012 |
not rated yet |
0
US watchdog warns on fitness stimulant
The US Food and Drug Administration on Friday questioned the safety of DMAA, a stimulant used in dietary supplements, alleging that marketers were illegally selling the chemical.
Medications
Apr 27, 2012 |
not rated yet |
1
Supreme Court ruling supports generic drug makers
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Medications
Apr 18, 2012 |
5 / 5 (1) |
0
Sushi 'tuna scrape' blamed for US salmonella outbreak
A ground fish product known as "tuna scrape," imported to the United States from India, was blamed Monday for a salmonella outbreak that has sickened 116 people, US health authorities said.
Diseases, Conditions, Syndromes
Apr 16, 2012 |
4 / 5 (1) |
0
FDA to decide on Qnexa obesity drug in July
US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.
Medications
Apr 10, 2012 |
not rated yet |
0
US warns of cancer-agent in Japan weight loss pills
The US Food and Drug Administration on Tuesday warned consumers not to take a product called "Japan Rapid Weight Loss Diet Pills" because they contain a suspected cancer-causing agent.
Medications
Apr 03, 2012 |
not rated yet |
0
Experts challenge FDA over approval for new dose of Alzheimer's drug
Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today. ...
Alzheimer's disease & dementia
Mar 22, 2012 |
5 / 5 (1) |
0
Coke, Pepsi to drop level of 'cancer' chemical
Coca-Cola and Pepsi said Friday they have lowered levels of a chemical in caramel coloring to comply with a California law, but insisted the drinks pose no health risks and recipes will not change.
Health
Mar 09, 2012 |
3 / 5 (2) |
1
Pfizer recalls 1 million packets of US birth control pills
US pharmaceutical giant Pfizer on Wednesday recalled one million packets of birth control pills over a packaging error that could put women at risk of unintended pregnancy.
Medications
Feb 01, 2012 |
not rated yet |
1
